• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药代动力学——应用与滥用

Pharmacokinetics--uses and abuses.

作者信息

Fell P J, Stevens M T

出版信息

Eur J Clin Pharmacol. 1975 Apr 4;8(3-4):241-8. doi: 10.1007/BF00567122.

DOI:10.1007/BF00567122
PMID:823032
Abstract

It is apparent from studying recent articles on pharmacokinetics that a number of misunderstandings exist, both about the design of experiments and the analysis of results. The purpose of this paper is to outline many of the common pitfalls associated with the design of experiments and also the limitations upon the analysis of results. The paper describes mathematical, laboratory and clinical aspects which must be examined in designing a protocol for pharmacokinetic experiments. Simulated data is presented to demonstrate the dangers of using standard computer programs for parameter estimation. Even when convergence is obtained the answers may be dependent on the method employed. A mathematical model is of little use unless a reasonable amount of good, accurate data is obtained.

摘要

从近期关于药代动力学的文章研究中可以明显看出,在实验设计和结果分析方面存在一些误解。本文的目的是概述与实验设计相关的许多常见陷阱以及结果分析的局限性。本文描述了在设计药代动力学实验方案时必须考虑的数学、实验室和临床方面。通过模拟数据展示了使用标准计算机程序进行参数估计的风险。即使获得了收敛结果,答案也可能取决于所采用的方法。除非获得合理数量的良好、准确的数据,否则数学模型用处不大。

相似文献

1
Pharmacokinetics--uses and abuses.药代动力学——应用与滥用
Eur J Clin Pharmacol. 1975 Apr 4;8(3-4):241-8. doi: 10.1007/BF00567122.
2
OPT: a package of computer programs for parameter optimisation in clinical pharmacokinetics.OPT:一套用于临床药代动力学参数优化的计算机程序。
Br J Clin Pharmacol. 1982 Aug;14(2):247-56. doi: 10.1111/j.1365-2125.1982.tb01969.x.
3
The use of computers in pharmacokinetics.计算机在药代动力学中的应用。
Int J Clin Pharmacol Biopharm. 1978 Aug;16(8):345-50.
4
Pharmacokinetic lag time estimation.
Int J Biomed Comput. 1985 Nov;17(3-4):193-6. doi: 10.1016/0020-7101(85)90022-4.
5
Two-compartment pharmacokinetic models: computer simulations of their characteristics and clinical consequences.
J Pharm Sci. 1981 Feb;70(2):141-6. doi: 10.1002/jps.2600700207.
6
Parameter optimisation in clinical pharmacokinetics.临床药代动力学中的参数优化
Comput Programs Biomed. 1982 Jun;14(3):239-48. doi: 10.1016/0010-468x(82)90029-0.
7
PHARM--an interactive graphic program for individual and population pharmacokinetic parameter estimation.PHARM——一款用于个体和群体药代动力学参数估计的交互式图形程序。
Comput Biol Med. 1984;14(1):25-34. doi: 10.1016/0010-4825(84)90017-9.
8
Application of new measures of nonlinearity to parameter estimation and simulations in individual pharmacokinetic analyses.将新的非线性度量应用于个体药代动力学分析中的参数估计和模拟。
J Pharmacokinet Pharmacodyn. 2019 Feb;46(1):43-52. doi: 10.1007/s10928-018-09616-1. Epub 2019 Jan 3.
9
[Practical evaluation of methods in pharmacokinetics].
Arzneimittelforschung. 1975 Jul;25(7a):1148-52.
10
An iterative curve stripping technique for pharmacokinetic parameter estimation.一种用于药代动力学参数估计的迭代曲线剥离技术。
J Pharm Pharmacol. 1986 Feb;38(2):97-101. doi: 10.1111/j.2042-7158.1986.tb04519.x.

引用本文的文献

1
Optimal sampling times for pharmacokinetic experiments.药代动力学实验的最佳采样时间。
J Pharmacokinet Biopharm. 1981 Dec;9(6):739-56. doi: 10.1007/BF01070904.
2
Variability in derived parameters of furosemide pharmacokinetics.呋塞米药代动力学衍生参数的变异性。
J Pharmacokinet Biopharm. 1981 Oct;9(5):623-33. doi: 10.1007/BF01061029.
3
Pharmacokinetics of intravenous glibenclamide investigated by a high performance liquid chromatographic assay.采用高效液相色谱法测定静脉注射格列本脲的药代动力学。

本文引用的文献

1
Blood level or pharmacological response?血药浓度还是药理反应?
Br J Clin Pharmacol. 1974 Feb;1(1):11. doi: 10.1111/j.1365-2125.1974.tb00199.x.
2
Investigation of the effect of data error in the analysis of biological tracer data.生物示踪数据分析中数据误差的影响研究。
Biophys J. 1967 Nov;7(6):903-11. doi: 10.1016/S0006-3495(67)86628-1. Epub 2008 Dec 31.
3
VARIATION IN RATE OF SALICYLATE ELIMINATION BY HUMANS.人类水杨酸盐消除速率的差异。
Diabetologia. 1982 Jul;23(1):37-40. doi: 10.1007/BF00257728.
4
Renal excretion of intravenously infused amoxycillin and ampicillin.静脉输注阿莫西林和氨苄西林后的肾脏排泄情况。
Br J Clin Pharmacol. 1985 Feb;19(2):191-201. doi: 10.1111/j.1365-2125.1985.tb02631.x.
5
Therapeutic drug monitoring in the neonate and paediatric age group. Problems and clinical pharmacokinetic implications.新生儿及儿童年龄组的治疗药物监测。问题及临床药代动力学影响。
Clin Pharmacokinet. 1990 Jul;19(1):1-10. doi: 10.2165/00003088-199019010-00001.
6
Digoxin pharmacokinetics: multicompartmental analysis and its clinical implications.地高辛药代动力学:多房室分析及其临床意义。
Br J Clin Pharmacol. 1976 Apr;3(2):221-9. doi: 10.1111/j.1365-2125.1976.tb00596.x.
7
Pharmacokinetic data. Pharmacokinetic parameters estimated from intravenous data by uniform methods and some of their uses.药代动力学数据。通过统一方法从静脉给药数据估算的药代动力学参数及其一些用途。
J Pharmacokinet Biopharm. 1977 Apr;5(2):161-82. doi: 10.1007/BF01066219.
8
Bioavailability of drugs: the digoxin dilemma.药物的生物利用度:地高辛的困境。
Clin Pharmacokinet. 1976;1(1):36-51. doi: 10.2165/00003088-197601010-00004.
9
Clinical pharmacokinetics of pancuronium bromide.泮库溴铵的临床药代动力学。
Eur J Clin Pharmacol. 1976 Sep 30;10(5):367-72. doi: 10.1007/BF00565627.
10
Curve fitting and modeling in pharmacokinetics: a response.药代动力学中的曲线拟合与建模:一则回应。
J Pharmacokinet Biopharm. 1978 Oct;6(5):443-6. doi: 10.1007/BF01062725.
Br Med J. 1964 Aug 1;2(5404):286-8. doi: 10.1136/bmj.2.5404.286.
4
SOME POSSIBLE ERRORS IN THE PLOTTING AND INTERPRETATION OF SEMILOGARITHMIC PLOTS OF BLOOD LEVEL AND URINARY EXCRETION DATA.
J Pharm Sci. 1963 Nov;52:1097-101. doi: 10.1002/jps.2600521116.
5
Symposium on clinical drug evaluation and human pharmacology. VI. Difficulties in extrapolating data on metabolism of drugs from animal to man.临床药物评价与人体药理学研讨会。VI. 从动物到人类外推药物代谢数据的困难。
Clin Pharmacol Ther. 1962 May-Jun;3:374-80. doi: 10.1002/cpt196233374.
6
Kinetics of drug absorption, distribution, metabolism, and excretion.药物吸收、分布、代谢和排泄的动力学。
J Pharm Sci. 1961 Mar;50:181-92. doi: 10.1002/jps.2600500302.
7
Intertissue diffusion effect for inert fat-soluble gases.惰性脂溶性气体的组织间扩散效应
J Appl Physiol. 1965 Jul;20(4):621-7. doi: 10.1152/jappl.1965.20.4.621.
8
Ampicillin levels in human bile in the presence of biliary tract disease.存在胆道疾病时人体胆汁中的氨苄西林水平。
Br Med J. 1969 Jul 12;3(5662):88-9. doi: 10.1136/bmj.3.5662.88.
9
Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.将人体视为具有单室性质进行药代动力学分析时存在的缺点。
J Pharm Sci. 1968 Jan;57(1):117-23. doi: 10.1002/jps.2600570123.
10
Commentary. Drug distribution and pharmacologic effects.述评。药物分布与药理作用。
Clin Pharmacol Ther. 1971 Sep-Oct;12(5):734-42. doi: 10.1002/cpt1971125734.